Source: Sharecast
The London-listed sports nutrition, health and wellness group reported that revenue for the year ended 31 July rose 24% to about £107m, compared with £86m a year earlier, while adjusted EBITDA increased by around 19% from £26m.
Net cash at the year-end was also stronger than expected at about £18.5m, ahead of the £16.6m consensus forecast.
The company said the performance was driven by a strong second half, which contributed around £60m of sales, underpinned by its global growth strategy.
Looking ahead, Applied Nutrition said it expected revenue for the 2026 financial year to be above current consensus, which previously stood at £112.4m.
The firm said it remained confident that its B2B-focused model, broad product range and investment in new product development would continue to support growth and profitability.
“We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations,” said chief executive Thomas Ryder.
“Our focus and ambition remain as strong as ever – in delivering for our shareholders, customers and team - and we are excited about the opportunities we have in the pipeline for the year ahead.”
The company said it expects to publish its full results on or around 10 November.
At 0931 BST, shares in Applied Nutrition were up 8.41% at 142.24p.
Reporting by Josh White for Sharecast.com.
